Rapidly Expanding Access to Care for hiv in Tanah Papua (reach) 2012 2016


Annex 7: Sexually transmitted infections programming



Yüklə 5,63 Mb.
səhifə20/30
tarix21.01.2017
ölçüsü5,63 Mb.
#6083
1   ...   16   17   18   19   20   21   22   23   ...   30

Annex 7: Sexually transmitted infections programming


This annex is designed as a stand-alone document on STI control in Tanah Papua. It is provided as background to the STI section of the program description, (see section 2.5). It will also be used as for strategic planning on STI control with local counterparts at provincial and district level in Tanah Papua during the REACH program.

There are three sections. Section 1 provides a brief background on general approaches to STI control and describes the toolbox of STI control strategies that we will use for designing STI control activities in Tanah Papua. Section 2 looks at what we know about STIs and existing STI control programming in Tanah Papua. Section 3 covers strategic approaches and key activities and maps out two broad strategic approaches: Improve the quality of STI diagnosis and treatment at district hospital and puskesmas level (3.1); and targeted STI interventions for high prevalence populations including PPT, enhanced syndromic management and syphilis screening (3.2).



A7.1 Background on approaches to STI control

There are three big-picture things we know about STIs:



  • STIs are not all the same

  • STIs tend to be unevenly spread in the community

  • Populations with high rates of STIs are not all the same

We need to remember these three points when we are designing STI control programs. Table 15 looks at what each of these three things means for STI control.

Table 15: What we know about STIs and what that means for STI control

What we know about STIs

Explanation

What it means for STI control

STIs are not all the same


Gonorrhoea, chlamydia, syphilis chancroid, donovanosis and herpes, all have different patterns of transmission, different patterns of distribution, and are linked with different laboratory, diagnosis and treatment issues.

Strategies need to target each of the high prevalence STIs e.g., gonorrhoea, chlamydia and syphilis

STIs tend to be unevenly distributed in the community

People have different levels of risk of getting STIs. STI rates tend to be higher in some populations, and in some locations, than others.


Strategies need to target high prevalence STI populations

Populations with high rates of STIs are not all the same

Sexual risk behaviours, condom use, numbers of sexual partners and treatment seeking behaviour all vary across populations with high rates of STIs.

Strategies need to be tailored for FSWs, boyfriends of FSWs, MSM, waria and clients

There is a toolbox of evidence-based STI control strategies that we will use (see Box 2). The tool box has two parts:

  • Strategies that rely on laboratory diagnosis

  • Strategies that do not rely on laboratory diagnosis.


Box 2: Toolbox of STI control strategies

  1. Strategies that rely on laboratory diagnosis

    • Screening

      • Opportunistic screening

      • Mass screening

        • Universal

        • Targeted

    • Improved access to diagnosis and treatment

      • Strengthen laboratory capacity

      • Improve access to services

      • Improve compliance – single dose treatments

      • Reduce the interval to treatment

  1. Strategies that rely on presumptive diagnosis

    • Syndromic management

    • Presumptive treatment

      • Targeted periodic presumptive treatment (PPT)

      • Universal treatment




These strategies rely on treatment without a laboratory diagnosis. This is called presumptive treatment. We will now look at the situation in Tanah Papua and draw on the tool box of STI strategies to design a program of STI control activities most likely to reduce STI prevalence in Tanah Papua.



A7.2 STIs and STI programming in Tanah Papua

Based on available data, gonorrhoea, chlamydia and syphilis are the highest documented burden STIs in Tanah Papua with particularly high prevalence rates among FSWs.



A7.2.1 Gonorrhoea and chlamydia

Table 16 summarizes the gonorrhoea and chlamydia data for Papua and West Papua from the IBBS rounds in 2009 and 2011. On any one day 35-60 per cent of FSWs in Tanah Papua will have either gonorrhoea or chlamydia. The data suggest that rates may have been lower in sites that had implemented PPT in the period before the surveillance e.g., Jayapura.



A7.2.1.1 Gonococcal resistance to antibiotics

Indonesia has recent data on gonococcal antimicrobial sensitivity in Tanah Papua. In 2004, seventy two gonococci isolates from Papua were tested by the WHO Collaborating Centre in Sydney and confirmed resistance to penicillins, tetracyclines and fluoroquinolones.48 Following this survey the recommended treatment for gonorrhoea in National STI Guidelines was changed to cefixime. A further survey in Wamena in May 2011, linked to the IBBS, confirmed current sensitivity to cefixime.49 At a country level gonococcal antimicrobial sensitivity surveys are recommended on a three-yearly basis.

Table 16: Gonorrhoea and chlamydia data for Papua and West Papua, IBBS 2009 and 201150





Gonorrhoea

(%)


Chlamydia (%)

Gonorrhoea and/or chlamydia (%)

2009 IBBS

Direct sex workers

Sorong

35

41

58

Club/bar-based sex workers

Sorong

23

46

55

Direct sex workers

Mimika

22

23

38

Club/bar-based sex workers

Mimika

18

28

35

2011 IBBS

Direct sex workers

Jayapura

32.4

31.2

47.2

Club/bar-based sex workers

Jayapura

18.8

31.2

39.6

Street-based sex workers

Wamena

35.4

44.8

56.3

A7.2.2 Syphilis

Control of syphilis is more achievable than control of gonorrhoea, chlamydia or other STIs. The tests for syphilis are cheap and can be easily conducted at the clinic level. Effective drugs (injectable penicillin) are available and effective control strategies have been demonstrated internationally.

While we have syphilis data from multiple rounds of IBBS conducted in Tanah Papua, the syphilis results have often been poorly interpreted with inclusion of all past syphilis infections leading to overestimates of the prevalence of active infection. This is a common problem in Indonesia but could be easily corrected by review of raw data using the Government of Indonesia standardized case definition for active syphilis (TPHA positive, RPR greater than or equal to 1:8). Of the recent reported IBBS data, the 2007 data are the most reliable and indicate that syphilis is concentrated among FSWs, with less than 10 per cent prevalence of active infection among direct FSWs in Jayapura and Sorong.51

Effective syphilis control is achievable in Tanah Papua and the key is to focus on the early diagnosis and treatment of infectious syphilis. In terms of syphilis, there are four groups in the population:



  • People who have never been exposed to syphilis

  • People who have had syphilis in the past but been treated

  • People who have non-infectious syphilis and require treatment

  • People who have infectious syphilis (can transmit the infection) and require treatment

We need to keep in mind that clinicians and public health physicians have different priorities in the management of syphilis. From a clinical management perspective the priority is to treat all people with syphilis whether it is infectious or non-infectious. Public health physicians’ priority is to stop the transmission of infectious syphilis. This means they give priority to early diagnosis and treatment of people with infectious syphilis with high titre RPR results. While clinicians should continue to provide treatment for all people with syphilis whether infectious or not, public health strategies designed to reduce the transmission of syphilis in Indonesia should focus on the control of infectious syphilis through the identification and treatment of people with infectious syphilis.

To control infectious syphilis we will need to overhaul current clinical practice in Tanah Papua (and Indonesia) regarding diagnosis and management of syphilis. There is quite a large amount of testing going on – often on the wrong people, with the wrong combination of test kits, wrong diagnoses, overtreatment among sex workers, reluctance to use the first line drug (Penicillin) and non-compliance with the alternative (Doxycycline). Routine use of RPR testing with confirmatory TPHA for syphilis diagnosis appears low. This may be an unforeseen consequence of the introduction of TPHA RDT and the unfortunate misrepresentation of the TPHA RDT as a syphilis RDT in the National STI Guidelines52.

Treatment: Following a court case in Semarang many doctors in Indonesia have been reluctant or have refused to give intramuscular Penicillin injections – the first line treatment for syphilis – due to the possibility of anaphylactic shock. Common practice is to prescribe doxycycline twice daily for 30 days. Compliance with this treatment is often poor, especially among sex workers, in part due to the common side effect of nausea and diarrhoea. A small study conducted by Yayasan Kerti Praja in Bali in 2001-2002 found zero compliance with a full course of doxycycline treatment amongst a sample was approximately 100 FSWs. Fortunately, health staff in Papua and West Papua appear more willing to give Penicillin injections than health staff in other parts of Indonesia.

A7.2.2.1 What about yaws?

Yaws is often raised as an issue in interpreting data on the prevalence of treponemal seropositivity (TPHA positive). The same tests that are used for the diagnosis of syphilis (TPHA and RPR) are also used to diagnose yaws and people who have been exposed to yaws in the past will have the same serological pattern as people who have been exposed to syphilis in the past (TPHA positive). Yaws is not an STI but it is caused by different subspecies (pertenue) of the same family of organisms that causes syphilis - Treponema pallidum. Yaws is mainly found in humid rural tropical regions and is also known as Frambusia.

There is some evidence that yaws may still be present in Indonesia in small residual foci of infection in isolated rural areas (“where the highway ends”).53 In a survey of 37,000 people in West Sumatra in 1988, 114 cases of early yaws were diagnosed clinically, with 100 being treponemal seropositive. Whilst continued low level transmission of yaws in isolated areas would contribute to the prevalence of treponemal seropositivity in those areas there is no logical basis to suggest that yaws contributes to the higher treponemal seropositivity amongst FSWs and waria compared to low risk populations in Indonesia. It seems reasonable to assume that the higher treponemal seropositivity amongst FSWs and waria is due to sexual exposure to syphilis.

A7.2.3 Other STIs

There are a number of other STIs (that are known cofactors for HIV transmission) that are likely present in Tanah Papua but are under-diagnosed, under-treated and under-reported, including chancroid, donovanosis, genital herpes and trichomonas. Chancroid, donovanosis, genital herpes and syphilis are all genital ulcer diseases and therefore are strong cofactors for HIV transmission. A review of the results of enhanced syndromic management in brothel-based FSWs could provide valuable data on the prevalence of genital ulcer disease in Tanah Papua.



Chancroid (Haemophilus ducreyi) is a genital ulcer disease. There are no data available on the prevalence of chancroid in Tanah Papua. Chancroid is treatable with single dose azithromycin. This means the PPT program for gonorrhoea and chlamydia among FSWs would also be effective for chancroid.

Donovanosis is a chronic genital ulcer disease with low infectivity. There are no current data available on the prevalence of donovanosis in Tanah Papua however donovanosis was historically endemic in Tanah Papua and PNG. The largest recorded epidemic of donovanosis occurred in Merauke in Papua between 1922 and 1952 where 10,000 cases were identified from a population of less than 15,000. 54 Since the introduction of antibiotics, donovanosis is less common and tends to occur in small endemic foci in populations with poor access to STI diagnosis and treatment.55

Trichomonas – Trichomonas is under-diagnosed and under-treated throughout Indonesia. The recommended treatment, metronidazole (single 2gm oral dose), needs to be added to the national EDL so it can be available at puskesmas level. There is also scope to train private pharmacists (apoteks) to prescribe metronidazole for symptoms of vaginal infection in women who are not pregnant.

A7.2.4 STI laboratory capacity, diagnosis and treatment

A7.2.4.1 STI laboratory capacity

Most district hospital laboratories and puskesmas can conduct simple diagnostic tests for gonorrhoea (gram stain, methylene blue), syphilis (TPHA, RPR) and trichomonas (wet mount).56 There are definite areas of weakness including very weak supply chain management for laboratory reagents and supplies, use of the TPHA rapid diagnostic test as a stand-alone diagnostic test without running RPR titres, weak laboratory quality assurance systems and SOPs and poor infection control. Laboratory capacity appears weaker in West Papua than in Papua. While there are many areas of STI laboratory capacity that need strengthening at district hospital and puskesmas level in Tanah Papua, the required level of capacity is within reach. The more sophisticated STI diagnostic tests (PCR, gonococcal culture) are carried out at the Provincial Health Laboratory and, at this stage, are not planned to be provided at district hospital or puskesmas level.



A7.2.4.2 Key policies and experience

Many of the key building blocks for STI control programming are in place. There are National STI Guidelines, a National STI Control Strategy (2008-2012) and a national Essential Drug List (EDL). Clinics do not always have the latest version of the national guidelines and there are standard STI drugs that are not on the EDL (see 2.4.3). On the positive side, there is valuable experience in Papua in the use of enhanced syndromic management and periodic presumptive treatment in FSWs.



A7.2.4.3 National Essential Drug List

WHO issues a model list of 350 essential drugs, including basic STI drugs, which many countries use as a basis for their National Essential Drug List (EDL). National EDLs are used as a basis for procurement and supply of standardized generic drugs with selection based on disease burden and cost-effectiveness. The current EDL in Indonesia does not include a number of STI drugs that are listed in the National STI Guidelines including cefixime, azithromycin and metronidazole. The National EDL is reviewed by the Indonesian MoH approximately every four years. The last revision was in 2011. In 2003, the Indonesian HIV/AIDS Prevention and Care Project (IHPCP) and FHI sent a joint submission to the Committee responsible for the review supporting the inclusion of Azithromycin (for use in FSW populations) and Cefixime in the EDL. This was unsuccessful.



A7.2.5 Gaps in our knowledge of STI in Tanah Papua

There are a number of important gaps in what we know about STIs in Tanah Papua including:



  • Lack of data on STIs among MSM and waria

  • Lack of data on STIs among regular partners of FSWs (boyfriends and husbands)

  • Lack of data on STIs among general population

  • Lack of data on other STIs including chancroid, donovanosis, herpes and HPV

A7.3 Strategic approach and key activities

Objective: To reduce STI prevalence in high prevalence populations in Tanah Papua

Overarching Outcome: STI prevalence reduced in high prevalence populations in Tanah Papua

Outcome 1: Gonorrhoea, chlamydia and syphilis prevalence reduced among sex workers

Outcome 2: STI prevalence reduced among HIV-positive sex workers

Outcome 3: Quality of STI diagnosis and treatment services improved at hospital and puskesmas level in Papua and West Papua

Outcome 4: Increased uptake of standardized STI services for MSM and waria in selected sites

How will we do it?


To reduce the prevalence of STIs in Tanah Papua we need to use a combination of strategies that rely on laboratory diagnosis and strategies that rely on presumptive diagnosis. We need to use most of the STI control strategies in the toolbox (see Box 1). Countries with good access to high quality laboratory diagnosis can afford to focus on improving access to services. Countries with weaker laboratory systems, including Tanah Papua, need to include strategies that rely on presumptive diagnosis.

Two broad strategic approaches are needed:



  • Targeted STI interventions for high prevalence populations including PPT, enhanced syndromic management and syphilis screening (see 3.1)

  • Improve the quality of STI diagnosis and treatment at district hospital and puskesmas level (see 3.2)

A7.3.1 Targeted STI interventions for high prevalence populations

Targeted STI interventions based on presumptive diagnosis are designed as transition strategies implemented over a period of time to achieve rapid reductions in STI prevalence in high prevalence populations that have poor uptake of services. The plan over the longer term is to shift from strategies that rely on presumptive diagnosis to strategies that rely on laboratory diagnosis as prevalence drops and laboratory capacity improves.

The emphasis in targeted STI interventions is on the population rather than the individual. Similarly, the challenge is to achieve high (population) participation rates rather than (individual) demand for services. The interventions are not based on waiting for individuals to decide to go to a clinic for a check-up. Health staff can go out to a brothel with a supply of doxycycline and cefixime for PPT and condoms. NGO partners can map street sex work sites and work with health staff to provide PPT medications every three months.

The puskesmas and district hospitals , in partnership with local NGOs, will have a key role to play in the scale-up of standardized STI services for high prevalence populations including presumptive treatment on arrival, 3 monthly PPT, regular syphilis screening and PPT for sex workers’ boyfriends and husbands. Specific attention will be given to providing STI diagnosis and treatment for HIV-positive FSWs. Table 17 lists the recommended key strategies for each high prevalence population. This section then gives additional background on four of the recommended strategies – PPT (3.1.1), syphilis screening (3.2.2), enhanced syndromic management (3.1.3) and use of surveillance activities for STI control (3.1.4).



Table 17: Key strategies for targeted STI interventions for seven populations




Population

Key strategies

Indicative sites

1

Brothel-based sex workers

  • PPT on arrival

  • PPT at 3 monthly intervals

  • 100% condom use program

  • PPT for boyfriends of sex workers

  • Syphilis screening

  • Trial syphilis register – client record of serial TPHA, RPR results and treatment

  • Standard use of Penicillin injections (not doxycycline) for treatment of syphilis

  • Use surveillance for STI control: linked testing and treatment for gonorrhoea, chlamydia and syphilis during IBBS

  • Jayapura (Tanjung Elmo)

  • Manokwari

  • Sorong

2

HIV-positive sex workers

  • Early initiation ART

  • 100% condom use

  • PPT 3 monthly

  • 3 monthly syphilis testing

  • Use surveillance for STI control

  • Jayapura (Tanjung Elmo)

  • Manokwari

  • Sorong

  • Wamena

3

Street sex workers

  • PPT at 3 monthly intervals

  • 100% condom use program

  • PPT for boyfriends of sex workers

  • Syphilis screening

  • Trial syphilis register – client record of serial TPHA, RPR results and treatment

  • Standard use of Penicillin injections

  • Use surveillance for STI control

  • Jayapura

  • Wamena

4

Bar and massage parlours based sex workers

  • Work with bar owners to implement an ‘On arrival STI minimum package of services (MPS)’ including presumptive treatment for gonorrhoea and chlamydia, syphilis testing and treatment, HIV RDT and reinforcement of 100% condom use.

  • Follow-up with 3 monthly PPT

  • Trial sex worker-held STI treatment record at selected clinic implementing presumptive treatment and syphilis screening with sex workers in bars and massage parlours (e.g., Kalvari Clinic in Wamena)

  • Use surveillance for STI control




5

Regular partners of sex workers

  • Trial PPT for boyfriends of sex workers based in brothels (Tanjung Elmo)

  • Jayapura (Tanjung Elmo)

  • Wamena

6

MSM

  • Develop/adapt standardized algorithms for STI diagnosis and treatment for MSM

  • Support two puskesmas to act as demonstration sites delivering a minimum package of services for MSM

  • Fak Fak

  • Jayapura

7

Waria

  • Develop/adapt standardized algorithms for STI diagnosis and treatment for waria in Papua

  • Support two puskesmas to act as demonstration sites delivering a minimum package of services for waria in Papua

  • Fak Fak

  • Jayapura

A7.3.1.1 Periodic presumptive treatment

There is considerable experience in Indonesia and in Tanah Papua specifically, in the use of periodic presumptive treatment (PPT) for chlamydia and gonorrhoea with 1 g azithromycin and 400 mg cefixime.57 The Global Fund program supported three rounds of PPT amongst sex workers in selected sites in Tanah Papua in 2011.58 This recent experience in using PPT with brothel-based sex workers in Papua and West Papua is a definite plus. Unfortunately PPT has not been implemented in a way that will maximize impact. Faced with small unsustained reductions in STI prevalence health staff has started to question the usefulness of PPT. We need PPT to control STIs among FSWs in Tanah Papua. To improve the effectiveness of PPT, as measured by a reduction in the prevalence of STIs, we need to understand that PPT works best with:



  • Well-defined populations

  • High prevalence of STIs59

  • Low population mobility and turn-over

  • High coverage of PPT

  • High rates of condom use (ideally in conjunction with 100% condom use program)

PPT cannot work if FSWs have low condom use rates with clients and do not use condoms at all with their boyfriends. PPT can’t work if the boyfriends of FSWs are not treated as well. Otherwise, after taking the PPT drugs the FSW will just be re-infected. PPT needs to be high coverage, linked to condom use programs, and combined with PPT for boyfriends of FSWs.

A7.3.1.2 Syphilis screening

Indonesia has documented evidence of the effectiveness of syphilis screening in high prevalence populations. In 2003 the AusAID-supported IHPCP commissioned a pilot syphilis control and behaviour change program amongst waria in Bali involving Yayasan Kerti Praja and Yayasan Gaya Dewata. The baseline syphilis screen documented a prevalence of 26 per cent (35/132). The quality of case management was higher than is usual in Indonesia with high treatment coverage (97%), standard use of Penicillin injections, and short interval to treatment (9.7 days). The second syphilis screen in July-August 2003 documented a significant reduction in prevalence to 12 per cent (16/133).

The keys to effective syphilis screening include


  • Screening programs with high population coverage (participation rates)

  • Clear standardized case definitions for infectious syphilis, active infection and past infection

  • Rapid treatment with prioritization of high-titre cases

  • Standard use of Penicillin injections

  • Individual records of serial titres and treatment

A7.3.1.3 Targeted screening using enhanced syndromic management

Enhanced syndromic management (syndromic management plus simple laboratory tests) is an important STI control strategy in low resource settings but has its limitations. Even in high prevalence populations its accuracy can be limited. In 1999, AusAID supported an evaluation of syndromic management algorithms60 in Indonesia that showed that among FSWs syndromic management of cervical infections (gonorrhoea and chlamydia), with a Positive Predictive Value of 48 per cent, did not perform much better than random treatment.

Enhanced syndromic management has been used for targeted periodic screening in FSW populations in Indonesia over the past ten years with varying results. As with PPT, there are a number of factors that can undermine the effectiveness of enhanced syndromic management:


  • Availability of effective drugs for treatment

  • Lack of effective STI programs amongst boyfriends and male clients

  • Positive Predictive Value of the algorithms used in enhanced syndromic management

  • Frequency of the screening

  • Coverage amongst the FSW populations

  • Mobility in the FSW populations

The potential impact of the STI control strategy amongst FSWs will depend on a number of factors:

  • Mobility of the population

  • Coverage in the FSW population

  • Frequency of intervention

  • Syndromic management algorithms used and the quality of their application

  • Treatment coverage

  • Effectiveness of the STI drugs

A7.3.1.4 Use of surveillance activities for STI control

The largest scale and highest quality STI testing conducted in Indonesia, using sophisticated laboratory equipment and reagents (e.g., PCR for gonorrhoea and chlamydia), has been through the national surveillance system. The costs of sample collection, laboratory reagents and testing are centrally funded. Standard practice is that individuals who test positive, in accordance with unlinked anonymous testing methodology, are not treated. This is a wasted opportunity.

Prior to 2006, the IBBS protocol in Indonesia included STI syndromic diagnosis and management for all FSWs participating in the surveillance activity. This was a heavy workload demand and implementation was variable. In 2006 FHI introduced confidential linked testing with PCR for gonorrhoea and chlamydia and serological testing for syphilis for FSWs participating in the surveillance, with client-initiated return for treatment. This is an exciting initiative that hopefully will be scaled-up in Tanah Papua and implemented more broadly in Indonesia.

A7.3.2 Improve the quality of STI diagnosis and treatment at district hospitals and puskesmas level in Papua and West Papua

There are four reasons why it is important to improve the quality of STI diagnosis and treatment at the level of the puskesmas and district hospital:



  • The targeted STI interventions for high prevalence populations depend on the quality of STI diagnosis and treatment at puskesmas level. It will be puskesmas staff who provide the PPT drugs. The syphilis blood samples taken in a syphilis screening program for FSWs will be tested in a puskesmas or district hospital laboratory. Registers of syphilis tests results and treatment details (to improve the accuracy of diagnosis and reduce overtreatment) will be maintained by clinic staff.

  • This is a long term investment in improving the quality of, and demand for, STI services. A vision for the future is all individuals with STIs, including FSWs and MSM, attending STI clinics at the local puskesmas.

  • STI treatment during surveillance activities will rely on the quality of STI diagnosis and treatment at puskesmas and district hospitals

Activities:

  • Improve the supply and availability of a standardized list of STI laboratory reagents and supplies in puskesmas and district hospital laboratories

  • Work at the national level with to review the National EDL to ensure inclusion of key STI drugs including cefixime, azithromycin and metronidazole in the EDL. In the interim, work with the District Legislative Assemblies61 to approve procurement of STI drugs under the District health budgets62

Table 18: Standardized STI reagents and drugs by health facility




Puskesmas

CoE and other district hospitals

Provincial health laboratory

STI reagents

  • Gram stain

  • Methylene Blue

  • TPHA RDT

  • RPR

  • Wet mount




  • Gram stain

  • Methylene Blue

  • TPHA RDT

  • RPR




  • Gonococcal culture

  • PCR

  • Genotyping

  • HIV EQAS

  • TB EQAS

STI drugs

  • Benzathin Penicillin

  • Cefixime

  • Azithromycin

  • Metronidazole

  • Doxycycline

  • Benzathin Penicillin

  • Cefixime

  • Azithromycin

  • Metronidazole

  • Doxycycline

none




  • Improve the quality of syphilis diagnosis and treatment with attention to:

    • Early diagnosis of infectious cases

    • Standard use of Penicillin injections

    • Rapid treatment with prioritization of high-titre cases

    • Individual records of serial titres and treatment

    • Provide technical input to WHO Indonesia and the MoH AIDS Sub Directorate in the next revision of the National STI Guidelines with particular attention to:

      • Need for TPHA RDT to be used in conjunction with RPR for syphilis diagnosis

      • Clear case definition for active syphilis that uses both TPHA and RPR tests

      • Inclusion of a stand-alone section on serological diagnosis of syphilis

    • Ensure STI clinics and puskesmas perform serial RPR titres on all TPHA positive /RPR reactive samples

    • Establish registers of serial syphilis results and treatment details in clinics providing sexual health services to sex workers to reduce the likelihood of over-diagnosis and unnecessary repeat treatments.

  • Scale-up routine syphilis screening of antenates at first visit

  • Advocate for, and support, inclusion of sites in Tanah Papua in gonococcal antimicrobial sensitivity surveys conducted in Indonesia.

  • Develop/adapt standardized algorithms for STI diagnosis and treatment for MSM and waria and support two puskesmas to act as demonstration sites delivering minimum package of services for MSM and waria

  • Strengthen diagnosis and treatment for trichomonas at puskesmas and district hospitals and work with the MoH to ensure supply and availability of metronidazole

  • Adapt (based on the Thai manual) and distribute a training manual for laboratory technicians on STI diagnosis

  • Provide training in public health approaches to STI control.

Will it work?


The MoH looks to WHO for leadership on technical issues such as the case definition for syphilis, gonococcal antimicrobial sensitivity surveys, and unlinked anonymous surveillance methodology. We will need some level of WHO support to move ahead with these strategies.

How will we know?


The IBBS rounds will provide prevalence data for syphilis, gonorrhoea and chlamydia.

In terms of implementing these changes, the REACH monitoring system will record key information for each REACH-supported puskesmas. Examples include:



  • percentage of sites that have consistently had key STI-related reagents and drugs in stock over previous six months

  • percentage of pregnant women and neonates screened for syphilis

  • percentage of syphilis tests which correctly distinguish between active and former infection

In terms of providing services to high risk groups, the regular monitoring system can use clinic and quality control records to report on:

  • percentage of sex workers correctly diagnosed and treated according to protocols

  • Change in STI prevalence between new arrivals and repeat clinic visits

  • percentage of sex workers given PPT for their regular partners

Will the benefits last?


The benefits of changes to the national EDL and guidelines will last. Accurate syphilis diagnosis and effective treatment will require ongoing low cost support from the CoE post program. The best sustainability strategy for STI diagnosis and treatment for MSM and waria is increased demand from those communities for the services.

Yüklə 5,63 Mb.

Dostları ilə paylaş:
1   ...   16   17   18   19   20   21   22   23   ...   30




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin